Interphase detection of immunoglobulin heavy chain gene translocations with specific oncogene loci in 173 patients with B-cell lymphoma

被引:40
作者
Tamura, A
Miura, I
Iida, S
Yokota, S
Horiike, S
Nishida, K
Fujii, H
Nakamura, S
Seto, M
Ueda, R
Taniwaki, M [1 ]
机构
[1] Kyoto Prefectural Univ Med, Dept Internal Med 3, Kamigyo Ku, Kyoto 6020841, Japan
[2] Akita Univ, Dept Internal Med 3, Akita 0108543, Japan
[3] Kyoto First Red Cross Hosp, Dept Hematol, Kyoto 6050981, Japan
[4] Aichi Canc Res Inst, Dept Canc Chemotherapy, Nagoya, Aichi 4648681, Japan
[5] Aichi Canc Res Inst, Dept Lab Med, Nagoya, Aichi 4648681, Japan
[6] Nagoya City Univ, Sch Med, Dept Med 2, Nagoya, Aichi 4678601, Japan
关键词
D O I
10.1016/S0165-4608(01)00436-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To detect immunoglobulin heavy chain (IGH) gene translocations with specific oncogene loci, we established an interphase cytogenetic approach using double-color fluorescence in situ hybridization (DC-FISH), which we used to analyze 173 patients with B-cell lymphoma. DC-FISH using the IGH gene (14q32.3) in combination with c-MYC (8q24.1), BCL1 (11q13.3), BCL2 (18q21.3), BCL6 (3q27), and PAX-5 (9p13) gene probes detected IGH translocations in 70 (40.5%) of 173 patients. The partner genes involved in IGH translocations were identified in 56 (80%) of 70 patients, and fusion of the IGH gene with specific oncogenes was detected in 53 of 56 patients, particularly in interphase nuclei of 28 patients for whom cytogenetic analysis was not informative. The most common partner gene was BCL2 (19 patients; 27% of IGH translocation-positive patients), followed by BCL6 (16; 23%), BCL1 (11; 16%), c-MYC (7; 10%), and PAX-5 (2; 3%). These oncogenes were closely associated with subtypes of B-cell lymphoma. The other partners were 19q13 (BCL3), 6p25 (MUM1/IRF4), 1q36, and chromosome 8 identified in one patient each. Six of the nine patients with add(14)(q32) showed a BCL6/IGH translocation. Double translocations of the IGH gene were found in three patients; c-MYC+BCL1, c-MYC+BCL2, and c-MYC+BCL6 in each one. Interphase FISH using specific IGH-translocation probes is valuable for defining clinically meaningful subgroups of B-cell lymphoma. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 43 条
[1]  
ADACHI M, 1989, ONCOGENE, V4, P1073
[2]   A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue [J].
Akagi, T ;
Motegi, M ;
Tamura, A ;
Suzuki, R ;
Hosokawa, Y ;
Suzuki, H ;
Ota, H ;
Nakamura, S ;
Morishima, Y ;
Taniwaki, M ;
Seto, M .
ONCOGENE, 1999, 18 (42) :5785-5794
[3]   Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene [J].
Akasaka, T ;
Akasaka, H ;
Ueda, C ;
Yonetani, N ;
Maesako, Y ;
Shimizu, A ;
Yamabe, H ;
Fukuhara, S ;
Uchiyama, T ;
Ohno, H .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) :510-518
[4]  
Akasaka T, 1996, BLOOD, V88, P985
[5]  
BASTARD C, 1994, BLOOD, V83, P2423
[6]  
BLOOMFIELD CD, 1983, CANCER RES, V43, P2975
[7]   Detection of 11q13 rearrangements in hematologic neoplasias by double-color fluorescence in situ hybridization [J].
Coignet, LJA ;
Schuuring, E ;
Kibbelaar, RE ;
Raap, TK ;
Kleiverda, KK ;
Bertheas, MF ;
Wiegant, J ;
Beverstock, G ;
Kluin, PM .
BLOOD, 1996, 87 (04) :1512-1519
[8]   The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas [J].
Dierlamm, J ;
Baens, M ;
Wlodarska, I ;
Stefanova-Ouzounova, M ;
Hernandez, JM ;
Hossfeld, DK ;
De Wolf-Peeters, C ;
Hagemeijer, A ;
Van den Berghe, H ;
Marynen, P .
BLOOD, 1999, 93 (11) :3601-3609
[9]  
ERIKSON J, 1993, P NATL ACAD SCI USA, V80, P820
[10]   World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997 [J].
Harris, NL ;
Jaffe, ES ;
Diebold, J ;
Flandrin, G ;
Muller-Hermelink, HK ;
Vardiman, J ;
Lister, TA ;
Bloomfield, CD .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) :3835-3849